ÂÜÀòÂÒÂ×

Jenny McGovern has extensive work experience in the field of research and therapeutic development. Jenny is currently the Director and Non-Clinical Group Leader at Quell Therapeutics, where they have been working since August 2022. Prior to this role, they held the position of Associate Director and Non-Clinical Group Leader at the same company from September 2020 to August 2022. Before joining Quell Therapeutics, Jenny worked as a Senior Scientist at the company from April 2019 to September 2020.

Jenny's earlier professional history includes roles at prestigious institutions such as UCL, Imperial College London, and University College London. At UCL, they worked as a Research Associate from May 2016 to March 2019. At Imperial College London, they served as a Research Associate from October 2013 to November 2015, where their research focused on studying the effects of NKG2D on intestinal carcinogenesis under the supervision of Dr. Nadia Guerra. Prior to this, they held the position of Research Associate at University College London from October 2012 to October 2013, and earlier, they were a PhD Student at the same institution from October 2008 to November 2012.

Jenny also has experience working as a Research Project member at the University of Manchester from January 2008 to April 2008. Their professional journey started with a placement role as a student at Boehringer Ingelheim from July 2006 to June 2007.

Overall, Jenny McGovern has a diverse and extensive research background, with significant experience leading non-clinical teams in therapeutic development.

Jenny McGovern's education history begins in 2004 when they attended The University of Manchester. Jenny pursued a Bachelor of Science degree in Anatomical Sciences with Industrial Experience, which they completed in 2008. Afterward, in 2008, Jenny enrolled at UCL to further their education. Jenny studied Medicine and earned a PhD, which they completed in 2012.